Detalles de la búsqueda
1.
Minimal residual disease-driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLL.
Blood;
140(22): 2348-2357, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35921541
2.
Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study.
Hematol Oncol;
41(5): 877-883, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37392141
3.
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.
Am J Hematol;
98(12): 1856-1868, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37772428
4.
T-cell immune response after mRNA SARS-CoV-2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies.
Br J Haematol;
196(3): 548-558, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34649298
5.
Dose-adjusted EPOCH and rituximab for the treatment of double expressor and double-hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome.
Haematologica;
107(5): 1153-1162, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34289655
6.
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group.
Hematol Oncol;
39(3): 326-335, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33739461
7.
Early serum TARC reduction predicts prognosis in advanced-stage Hodgkin lymphoma patients treated with a PET-adapted strategy.
Hematol Oncol;
38(4): 501-508, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32602970
8.
Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas.
Oncologist;
24(8): e720-e729, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30552159
9.
Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network.
Hematol Oncol;
37(2): 160-167, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30726562
10.
Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network.
Am J Hematol;
94(11): 1193-1199, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31378966
11.
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study.
Haematologica;
103(7): 1209-1217, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29674504
12.
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study.
Am J Hematol;
98(9): E237-E240, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37382471
13.
Allogeneic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial including Rituximab in the Reduced-Intensity Conditioning Regimen.
Biol Blood Marrow Transplant;
23(7): 1102-1109, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28390983
14.
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.
Hematol Oncol;
39(4): 570-574, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34258787
15.
Comparative evaluation of biological human leukocyte antigen DPB1 mismatch models for survival and graft-versus-host disease prediction after unrelated donor hematopoietic cell transplantation.
Haematologica;
105(4): e186-e189, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31471374
16.
Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia.
Haematologica;
100(4): 511-6, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25596264
17.
Serum thymus and activation-regulated chemokine level monitoring may predict disease relapse detected by PET scan after reduced-intensity allogeneic stem cell transplantation in patients with Hodgkin lymphoma.
Biol Blood Marrow Transplant;
20(12): 1982-8, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25240818
18.
Impact of cytomegalovirus replication and cytomegalovirus serostatus on the outcome of patients with B cell lymphoma after allogeneic stem cell transplantation.
Biol Blood Marrow Transplant;
20(6): 885-90, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24583412
19.
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplantation for Patients with Hodgkin Lymphoma: A Comparative Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
Transplant Cell Ther;
30(2): 210.e1-210.e14, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38043802
20.
Long-term molecular remission with lenalidomide treatment of relapsed chronic lymphocytic leukemia.
Eur J Haematol;
90(4): 340-4, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23281656